pSivida Announces Top-Line Results from Investigator-Sponsored Phase II Study of Medidur for Uveitis to Be Reported Next Week
July 07, 2015 at 11:16 AM EDT
pSivida Corp. (NASDAQ: PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye ...
